EXHIBIT 1.1
HERSHA HOSPITALITY
TRUST
15,000,000 CLASS A COMMON SHARES
OF BENEFICIAL INTEREST
CONTROLLED EQUITY
OFFERING SM
SALES
AGREEMENT
June 12, 2009
Each of Hersha Hospitality Trust, a Maryland
real estate investment trust (the “ Company ”),
and Hersha Hospitality Limited Partnership, a Virginia limited
partnership (the “ Operating Partnership
”), confirms its agreement (this “
Agreement ”) with Cantor Fitzgerald & Co. (“
CF&Co ”), as follows:
1.
Issuance and Sale of Shares . The Company agrees
that, from time to time during the term of this Agreement, on the
terms and subject to the conditions set forth herein, it may issue
and sell through CF&Co, acting as agent and/or principal, up to
15,000,000 of the Company’s Class A common shares of
beneficial interest, par value $0.01 per share (“ Common
Shares ” or “ Shares
”). Notwithstanding anything to the contrary
contained herein, the parties hereto agree that compliance with the
limitation set forth in this Section 1 on the number of
Shares issued and sold under this Agreement shall be the sole
responsibility of the Company, and CF&Co shall have no
obligation in connection with such compliance. The
issuance and sale of Shares through CF&Co will be effected
pursuant to the Registration Statement (as defined below) filed by
the Company and declared effective by the Securities and Exchange
Commission (the “ Commission ”), although
nothing in this Agreement shall be construed as requiring the
Company to use the Registration Statement to issue
Shares.
The Company has filed, in accordance with the
provisions of the Securities Act of 1933, as amended, and the rules
and regulations thereunder (collectively, the “ Securities
Act ”), with the Commission a registration statement on
Form S-3 (File No. 333-138038), including a base prospectus,
relating to certain securities, including the Shares, to be issued
from time to time by the Company, and which incorporates by
reference documents that the Company has filed or will file in
accordance with the provisions of the Securities Exchange Act of
1934, as amended, and the rules and regulations thereunder
(collectively, the “ Exchange Act ”). Such
registration statement has become effective under the Securities
Act. The Company may file one or more additional
registration statements from time to time that will contain a base
prospectus with respect to the Shares. The Company shall prepare
one or more prospectus supplements specifically relating to the
Shares (collectively, the “ Prospectus Supplement
”) to the base prospectus included as part of each such
registration statement containing a base prospectus with respect to
the Shares. The Company shall furnish to
CF&Co, for use by CF&Co, copies of the prospectus included
as part of each such registration statement, as supplemented by the
Prospectus Supplement, relating to the Shares. Except
where the context otherwise requires, each such registration
statement, as amended when it became effective, including all
documents filed as part thereof or incorporated by reference
therein, and including any information contained in a Prospectus
(as defined below) subsequently filed with the Commission pursuant
to Rule 424(b) under the Securities Act or deemed to be part of
each such registration statement filed pursuant to Rule 430B or
462(b) of the Securities Act, is herein called the “
Registration Statement .” Each base prospectus,
including all documents incorporated therein by reference, included
in the Registration Statement, as it may be supplemented by the
Prospectus Supplement, in the form in which such prospectus and/or
Prospectus Supplement have most recently been filed by the Company
with the Commission pursuant to Rule 424(b) under the Securities
Act, together with any “issuer free writing
prospectus,” as defined in Rule 433 under the Securities Act
(“ Rule 433 ”), if any, relating to the offering
of the Shares, which (i) is required to be filed with the
Commission by the Company or (ii) is exempt from filing pursuant to
Rule 433(d)(5)(i), in each case in the form filed or required to be
filed with the Commission or, if not required to be filed, in the
form retained in the Company’s records pursuant to Rule
433(g), is herein called the “ Prospectus
.” Any reference herein to the Registration
Statement, the Prospectus or any amendment or supplement thereto
shall be deemed to refer to and include the documents incorporated
by reference therein, and any reference herein to the terms
“amend”, “amendment” or
“supplement” with respect to the Registration Statement
or the Prospectus shall be deemed to refer to and include the
filing after the execution hereof of any document with the
Commission deemed to be incorporated by reference
therein. For purposes of this Agreement, all references
to the Registration Statement, the Prospectus, or to any amendment
or supplement thereto shall be deemed to include any copy filed
with the Commission pursuant to its Electronic Data Gathering
Analysis and Retrieval System (“ EDGAR
”).
2.
Placements . Each time that the Company wishes to
issue and sell Shares hereunder (each, a “ Placement
”), it will notify CF&Co by email notice (or other method
mutually agreed to in writing by the parties) containing the
parameters in accordance with which it desires the Shares to be
sold, which shall at a minimum include the number of Shares to be
issued (the “ Placement Shares ”), the time
period during which sales are requested to be made, any limitation
on the number of Shares that may be sold in any one Trading Day (as
defined in Section 3 ) and any minimum price below which
sales may not be made (a “ Placement Notice ”),
a form of which containing such minimum sales parameters necessary
is attached hereto as Schedule 1 . The Placement
Notice shall originate from any of the individuals from the Company
set forth on Schedule 2 (with a copy to each of the other
individuals from the Company listed on such schedule), and shall be
addressed to each of the individuals from CF&Co set forth on
Schedule 2 , as such Schedule 2 may be amended from
time to time. The Placement Notice shall be effective upon receipt
by CF&Co unless and until (i) in accordance with the notice
requirements set forth in Section 4 , CF&Co declines to
accept the terms contained therein for any reason, in its sole
discretion, (ii) the entire amount of the Placement Shares have
been sold, (iii) in accordance with the notice requirements set
forth in Section 4 , the Company suspends or terminates the
Placement Notice, (iv) the Company issues a subsequent Placement
Notice with parameters superseding those on the earlier dated
Placement Notice, or (iv) the Agreement has been terminated under
the provisions of Section 11 . The amount
of any discount, commission or other compensation to be paid by the
Company to CF&Co in connection with the sale of the Placement
Shares shall be calculated in accordance with the terms set forth
in Schedule 3 . It is expressly acknowledged and
agreed that neither the Company nor CF&Co will have any
obligation whatsoever with respect to a Placement or any Placement
Shares unless and until the Company delivers a Placement Notice to
CF&Co and CF&Co does not decline such Placement Notice
pursuant to the terms set forth above, and then only upon the terms
specified therein and herein. In the event of a conflict
between the terms of this Agreement and the terms of a Placement
Notice, the terms of the Placement Notice will control.
3.
Sale of Placement Shares by CF&Co. Subject
to the terms and conditions herein set forth, upon the
Company’s issuance of a Placement Notice, and unless the sale
of the Placement Shares described therein has been declined,
suspended, or otherwise terminated in accordance with the terms of
this Agreement, CF&Co, for the period specified in the
Placement Notice, will use its commercially reasonable efforts
consistent with its normal trading and sales practices to sell such
Placement Shares up to the amount specified, and otherwise in
accordance with the terms of such Placement
Notice. CF&Co will provide written confirmation to
the Company no later than the opening of the Trading Day (as
defined below) immediately following the Trading Day on which it
has made sales of Placement Shares hereunder setting forth the
number of Placement Shares sold on such day, the compensation
payable by the Company to CF&Co pursuant to Section 2
with respect to such sales, and the Net Proceeds (as defined below)
payable to the Company, with an itemization of the deductions made
by CF&Co (as set forth in Section 5(a) ) from the gross
proceeds that it receives from such sales. After
consultation to the Company and subject to the terms of the
Placement Notice, CF&Co may sell Placement Shares by any method
permitted by law deemed to be an “at the market”
offering as defined in Rule 415 of the Securities Act, including
without limitation sales made directly on the New York Stock
Exchange (the “ Exchange ”), on any other
existing trading market for the Shares or to or through a market
maker. After consultation with the Company and subject
to the terms of the Placement Notice, CF&Co may also sell
Placement Shares in privately negotiated
transactions. The Company acknowledges and agrees that
(i) there can be no assurance that CF&Co will be successful in
selling Placement Shares, and (ii) CF&Co will incur no
liability or obligation to the Company or any other person or
entity if it does not sell Placement Shares for any reason other
than a failure by CF&Co to use its commercially reasonable
efforts consistent with its normal trading and sales practices to
sell such Placement Shares as required under this Section 3
. For the purposes hereof, “ Trading Day
” means any day on which the Company’s common shares of
beneficial interest are purchased and sold on the principal market
on which the common shares of beneficial interest are listed or
quoted.
4.
Suspension of Sales . The Company or CF&Co
may, upon notice (the “ Suspension Notice ”) to
the other party in writing (including by email correspondence to
each of the individuals of the other Party set forth on Schedule
2 , if receipt of such correspondence is actually acknowledged
by any of the individuals to whom the notice is sent, other than
via auto-reply) or by telephone (confirmed immediately by
verifiable facsimile transmission or email correspondence to each
of the individuals of the other Party set forth on Schedule
2 ), suspend any sale of Placement Shares; provided,
however , that such suspension shall not affect or impair
either party’s obligations with respect to any Placement
Shares sold hereunder prior to the receipt of such
notice. Each of the Parties agrees that no such notice
under this Section 4 shall be effective against the other
unless it is made to one of the individuals named on Schedule
2 hereto, as such Schedule may be amended from time to
time.
(a)
Settlement of Placement Shares . Unless otherwise
specified in the applicable Placement Notice, settlement for sales
of Placement Shares will occur on the third (3 rd )
Trading Day (or such earlier day as is industry practice for
regular-way trading) following the date on which such sales are
made (each, a “ Settlement Date
”). The amount of proceeds to be delivered to the
Company on a Settlement Date against receipt of the Placement
Shares sold (the “ Net Proceeds ”) will be equal
to the aggregate sales price received by CF&Co at which such
Placement Shares were sold, after deduction for (i)
CF&Co’s commission, discount or other compensation for
such sales payable by the Company pursuant to Section 2
hereof, (ii) any other amounts due and payable by the Company to
CF&Co hereunder pursuant to Section 7(h) (Expenses)
hereof, and (iii) any transaction fees imposed by any governmental
or self-regulatory organization in respect of such
sales.
(b)
Delivery of Placement Shares . On or before each
Settlement Date, the Company will, or will cause its transfer agent
to, electronically transfer the Placement Shares being sold by
crediting CF&Co’s or its designee’s account
(provided CF&Co shall have given the Company written notice of
such designee prior to the Settlement Date) at The Depository Trust
Company through its Deposit and Withdrawal at Custodian System or
by such other means of delivery as may be mutually agreed upon by
the parties hereto which in all cases shall be freely tradeable,
transferable, registered shares in good deliverable
form. On each Settlement Date, CF&Co will deliver
the related Net Proceeds in same day funds to an account designated
by the Company on, or prior to, the Settlement Date. The
Company agrees that if the Company, or its transfer agent (if
applicable), defaults in its obligation to deliver Placement Shares
on a Settlement Date, the Company agrees that in addition to and in
no way limiting the rights and obligations set forth in Section
9(a) (Indemnification and Contribution) hereto, it will (i)
hold CF&Co harmless against any loss, claim, damage, or expense
(including reasonable legal fees and expenses), as incurred,
arising out of or in connection with such default by the Company
and (ii) pay to CF&Co any commission, discount, or other
compensation to which it would otherwise have been entitled absent
such default.
6.
Representations and Warranties of the Company and the Operating
Partnership . The Company and the Operating
Partnership, jointly and severally represent and warrant to, and
agree with, CF&Co that as of the date of this Agreement and as
of each Representation Date (as defined in Section 7(n)
below) on which a certificate is required to be delivered pursuant
to Section 7(n) of this Agreement and as of each Applicable
Time, as the case may be:
(a) The
Company meets the requirements for use of Form S-3 under the
Securities Act. The Registration Statement has been
filed with the Commission and has been declared effective under the
Securities Act. The Company has prepared or will prepare
the Prospectus Supplement that names CF&Co as an underwriter,
acting as principal and/or agent, in the section entitled
“Plan of Distribution.” The
Company has not received, and has no knowledge of, any order of the
Commission preventing or suspending the use of the Registration
Statement, or threatening or instituting proceedings for that
purpose. Any statutes, regulations, contracts or other
documents that are required to be described in the Registration
Statement or the Prospectus or to be filed as exhibits to the
Registration Statement have been so described or
filed. The Prospectus Supplement has been so prepared
and will be filed pursuant to Rule 424(b) of the Securities Act
within the time period prescribed therein. Copies
of the Registration Statement, the Prospectus, and any such
amendments or supplements and all documents incorporated by
reference therein that were filed with the Commission on or prior
to the date of this Agreement have been delivered, or made
available, to CF&Co and its counsel. The Common
Stock is currently listed on the Exchange under the trading symbol
“HT.”
(b) The
Prospectus delivered to CF&Co for use in connection with the
offering of Shares will, at the time of such delivery, be identical
to the electronically transmitted copies thereof filed with the
Commission pursuant to EDGAR, except to the extent permitted by
Regulation S-T.
(c) Each
of the Registration Statement, any Rule 462(b) Registration
Statement and each amendment thereto, at the time it became
effective, at each deemed effective date with respect to CF&Co
pursuant to Rule 430B(f)(2) of the Securities Act, and as of each
Applicable Time, as the case may be, complied and will comply in
all material respects with the requirements of the Securities Act,
and did not and will not contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein not misleading. The
preceding sentence does not apply to statements in or omissions
from the Registration Statement, any Rule 462(b) Registration
Statement or any amendment thereto in reliance upon and in
conformity with written information relating to CF&Co furnished
to the Company in writing by CF&Co expressly for use therein,
it being understood and agreed that the only such information
furnished by CF&Co consists of the information described as
such in Schedule 4 hereto.
(d) Neither
the Prospectus nor any amendments or supplements thereto, at the
time the Prospectus or any such amendment or supplement was issued,
as of the date hereof, each Applicable Time, and at each
Representation Date, as the case may be, included or will include
an untrue statement of a material fact or omitted or will omit to
state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were
made, not misleading. The preceding sentence does not apply to
statements in or omissions from the Prospectus, as amended or
supplemented, in reliance upon and in conformity with written
information relating to CF&Co furnished to the Company in
writing by CF&Co expressly for use therein, it being understood
and agreed that the only such information furnished by CF&Co
consists of the information described as such in Schedule 4
hereto.
(e) Each
document incorporated by reference in the Registration Statement or
the Prospectus heretofore filed, when it was filed (or, if any
amendment with respect to any such document was filed, when such
amendment was filed), conformed in all material respects with the
requirements of the Exchange Act and the rules and regulations
thereunder, and any further documents so filed and incorporated
after the date of this Agreement will, when they are filed, conform
in all material respects with the requirements of the Exchange Act
and the rules and regulations thereunder; no such document when it
was filed (or, if an amendment with respect to any such document
was filed, when such amendment was filed), contained an untrue
statement of a material fact or omitted to state a material fact
required to be stated therein or necessary in order to make the
statements therein not misleading; and no such document, when it is
filed, will contain an untrue statement of a material fact or will
omit to state a material fact required to be stated therein or
necessary in order to make the statements therein not
misleading.
(f)
Each issuer free writing prospectus (as defined in Rule 433), as of
its issue date and at all subsequent times through the completion
of the public offer and sale of the Shares or until any earlier
date that the Company notifies CF&Co in writing, did not, does
not and will not include any information that conflicted, conflicts
or will conflict with the information contained in the Registration
Statement or the Prospectus, including any incorporated document
deemed to be a part thereof that has not been superseded or
modified. The foregoing sentence does not apply to statements in or
omissions from any issuer free writing prospectus based upon and in
conformity with written information furnished to the Company by
CF&Co specifically for use therein, it being understood and
agreed that the only such information furnished by CF&Co
consists of the information described as such in Schedule 4
hereto.
(g)
All of the issued and outstanding shares of beneficial interest of
the Company have been duly authorized and validly issued, are fully
paid and nonassessable and have been issued in compliance with
applicable federal and state securities laws. None of
the outstanding shares of beneficial interest of the Company were
issued in violation of any preemptive rights, rights of first
refusal or other similar rights; except as set forth in the
Prospectus, there are no outstanding options, warrants or similar
rights to subscribe for, or contractual obligations to issue, sell,
transfer or acquire, any shares of beneficial interest of the
Company or any securities convertible into or exchangeable for any
such shares of beneficial interest; the Placement Shares to be
issued and sold by the Company hereunder have been duly authorized
and, when issued and delivered against full payment therefor in
accordance with the terms hereof, will be validly issued, fully
paid and nonassessable and free of any preemptive rights, rights of
first refusal or other or similar rights; and the shares of
beneficial interest of the Company, including the Placement Shares,
conform to the description thereof contained in the Prospectus. The
certificates for the Placement Shares are in due and proper form
and the holders of the Shares will not be subject to personal
liability by reason of being such a holder.
(h) Immediately
after the transactions contemplated by this Agreement, all of the
issued and outstanding Common Units and Preferred Units (each, as
defined below) will have been or will be validly issued and fully
paid and non-assessable. Immediately after the
transactions contemplated by this Agreement, none of the
outstanding common units of limited partnership interest in the
Operating Partnership (“ Common Units ”) or
preferred units of limited partnership interest in the Operating
Partnership (“ Preferred Units ”) will have been
issued in violation of any preemptive right, right of first refusal
or other similar right; and the outstanding Common Units and
Preferred Units have been offered, sold and issued by the Operating
Partnership in compliance with applicable federal and state
securities laws.
(i) The
Company does not own or control, directly or indirectly, any
corporation, association or other entity other than (i) the
subsidiaries that are listed in Exhibit 21.1 to the Company’s
Annual Report on Form 10-K for the most recently ended fiscal year
and (ii) those subsidiaries formed since the last day of the most
recently ended fiscal year (each a “ Subsidiary
” and collectively, the “ Subsidiaries
”).
(j) Each
of the Company and the Subsidiaries that are consolidated with the
Company in the Company’s financial statements in accordance
with generally accepted accounting principles (the “
Consolidated Subsidiaries ”) is duly organized and
validly existing in good standing under the laws of the state of
its incorporation or organization with full corporate, partnership
or entity power and authority, as the case may be, to own, lease
and operate its properties and to conduct its business as presently
conducted and as described in the Prospectus and is duly registered
and qualified to conduct its business and is in good standing in
each jurisdiction or place where the nature of its properties or
the conduct of its business requires such registration or
qualification, except where the failure to so register or qualify
has not had or will not have a material adverse effect on the
condition (financial or other), business, properties, results of
operations or prospects of the Company and the Consolidated
Subsidiaries, taken as a whole (a “ Material Adverse
Effect ”).
(k) The
outstanding equity interests of, or other ownership interests in,
each of the Consolidated Subsidiaries have been duly authorized and
validly issued, are fully paid and, except as to Consolidated
Subsidiaries that are partnerships or limited liability companies,
nonassessable and are, or will be, owned by the Company, directly
or indirectly, free and clear of any security interest, lien,
encumbrance or claim.
(l) Except
as described in the Prospectus, there is no action, suit, inquiry,
proceeding or investigation by or before any court or governmental
or other regulatory or administrative agency or commission pending
or, to the best knowledge of the Company, threatened, against or
involving the Company or any Consolidated Subsidiary, which might
individually or in the aggregate prevent or adversely affect the
transactions contemplated by this Agreement or result in a Material
Adverse Effect, nor to the Company's knowledge, is there any basis
for any such action, suit, inquiry, proceeding or investigation.
There are no agreements, contracts, indentures, leases or other
instruments that are required to be described in the Prospectus or
to be filed as an exhibit to the Registration Statement that are
not described, filed or incorporated by reference in the
Registration Statement and the Prospectus as required by the
Securities Act. All such contracts to which the Company
or any Consolidated Subsidiary is a party have been duly
authorized, executed and delivered by the Company or the applicable
Consolidated Subsidiary, constitute valid and binding agreements of
the Company or the applicable Consolidated Subsidiary and are
enforceable against the Company or the applicable Consolidated
Subsidiary in accordance with the terms thereof, except as
enforceability thereof may be limited by (i) the application of
bankruptcy, reorganization, insolvency and other laws affecting
creditors' rights generally and (ii) equitable principles being
applied at the discretion of a court before which any proceeding
may be brought. Neither the Company nor any Consolidated
Subsidiary has received written notice or been made aware that the
Company or any Consolidated Subsidiary is in breach of or default
under any such contracts to which it is a party.
(m) Neither
the Company nor any Consolidated Subsidiary is (i) in violation of
(A) its Organizational Documents, (B) to the Company's knowledge,
any law, ordinance, administrative or governmental rule or
regulation applicable to the Company or any Consolidated
Subsidiary, the violation of which would have a Material Adverse
Effect or (C) any decree of any court or governmental agency or
body having jurisdiction over the Company or any Consolidated
Subsidiary; or (ii) in default in any material respect in the
performance of any obligation, agreement or condition contained in
(x) any bond, debenture, note or any other evidence of indebtedness
or (y) any agreement, indenture, lease or other instrument (each of
(x) and (y), an “ Existing Instrument ”) to
which the Company or any Consolidated Subsidiary is a party or by
which any of its properties may be bound, which default would have
a Material Adverse Effect; and to the Company’s knowledge,
there does not exist any state of facts that constitutes a default
or an event of default on the part of the Company or any
Consolidated Subsidiary as defined in such documents or that, with
notice or lapse of time or both, would constitute such a default or
event of default which would have a Material Adverse
Effect.
(n) Each
of the Company and the Operating Partnership has full legal right,
power and authority to enter into and perform this Agreement and to
consummate the transactions contemplated herein, including the
issuance, sale and delivery of the Placement Shares as provided
herein and the Operating Partnership’s issuance of the Common
Units to the Company. The Company’s and the
Operating Partnership’s execution and delivery of this
Agreement and the performance by the Company and the Operating
Partnership of their obligations under this Agreement have been
duly and validly authorized by the Company and the Operating
Partnership and this Agreement has been duly executed and delivered
by the Company and the Operating Partnership, and constitutes a
valid and legally binding agreement of the Company and the
Operating Partnership, enforceable against the Company and the
Operating Partnership in accordance with its terms, except to the
extent enforceability may be limited by (i) the application of
bankruptcy, reorganization, insolvency and other laws affecting
creditors' rights generally (regardless of whether enforcement is
sought in a proceeding in equity or at law) and (ii) equitable
principles being applied at the discretion of a court before which
any proceeding may be brought, and except as rights to indemnity
and contribution hereunder may be limited by federal or state
securities laws.
(o) The
Amended and Restated Agreement of Limited Partnership of the
Operating Partnership, including all amendments thereto (the
“ Partnership Agreement ”), has been duly and
validly authorized, executed and delivered by the general partner
of the Operating Partnership and constitutes a valid and binding
agreement of the general partner, enforceable in accordance with
its terms, except to the extent that enforceability may be limited
by bankruptcy, insolvency, reorganization or other laws of general
applicability relating to or affecting creditors' rights or by
general equity principles.
(p) No
consent, approval, authorization, order, license, certificate,
permit, registration, designation or filing by or with any
governmental agency or body is required for the execution, delivery
and performance by the Company and the Operating Partnership of
their respective obligations under this Agreement and the
consummation by the Company and the Operating Partnership of the
transactions contemplated hereby, including the valid
authorization, issuance, sale and delivery of the Placement Shares,
except such as have been obtained or made and may be required by
(i) the Exchange and (ii) the securities or Blue Sky laws of the
various states in connection with the offer and sale of the
Placement Shares.
(q) Neither
the issuance and sale of the Placement Shares by the Company, the
execution, delivery or performance of this Agreement by the Company
and the Operating Partnership nor the consummation by the Company
and the Operating Partnership of the transactions contemplated
hereby (i) conflicts with or will conflict with or constitutes or
will constitute a breach of, or a default under, the Company's
declaration of trust, as amended or supplemented, or bylaws, the
Operating Partnership's certificate of limited partnership or the
Operating Partnership Agreement, or any Existing Instrument to
which the Company or any Consolidated Subsidiary is a party or by
which any of its respective properties may be bound, (iii) violates
any statute, law, regulation, ruling, filing, judgment, injunction,
order or decree applicable to the Company or any Consolidated
Subsidiary or any of their properties, or (iv) results in a breach
of, or default or Debt Repayment Triggering Event (as defined
below) under, or results in the creation or imposition of any lien,
charge or encumbrance upon any property or assets of the Company or
any Consolidated Subsidiary pursuant to, or requires the consent of
any other party to, any Existing Instrument, except for such
conflicts, breaches, defaults, liens, charges or encumbrances that
will not, individually or in the aggregate, result in a Material
Adverse Effect. As used herein, a “ Debt Repayment
Triggering Event ” means any event or condition that
gives, or with the giving of notice or lapse of time would give,
the holder of any note, debenture or other evidence of indebtedness
(or any person acting on such holder's behalf) the right to require
the repurchase, redemption or repayment of all or a portion of such
indebtedness by the Company or any Consolidated
Subsidiary.
(r) Other
than owners of Common Units by persons other than the Company, no
holder of any securities of the Company has rights to the
registration of any securities of the Company or other similar
rights as a result of or in connection with the filing of the
Registration Statement or the consummation of the transactions
contemplated hereby that have not been satisfied or heretofore
waived in writing. No person or entity has a right of participation
or first refusal with respect to the sale of the Shares by the
Company.
(s) KPMG
LLP, who has audited the consolidated financial statements of the
Company and the Consolidated Subsidiaries (including the related
notes thereto and supporting schedules) incorporated by reference
in the Registration Statement and the Prospectus, is and was,
during the periods covered by its reports incorporated by reference
in the Registration Statement and the Prospectus, independent
registered public accountants as required by the Securities Act,
the Exchange Act and the Public Company Accounting Oversight Board
(“ PCAOB ”). PricewaterhouseCoopers
LLP, who has audited the consolidated statements of operations, of
changes in members’ equity and of cash flows of Mystic
Partners, LLC and its subsidiaries (including the related notes and
supporting schedules thereto) for the year ended December 31, 2006
incorporated by reference in the Registration Statement and the
Prospectus, is and was, during the periods covered by its reports
incorporated by reference in the Registration Statement and the
Prospectus, independent registered public accountants as required
by the Securities Act, the Exchange Act and PCAOB.
(t) The
financial statements, together with related schedules and notes,
included or incorporated by reference in the Registration Statement
and the Prospectus, present fairly the financial condition, results
of operations, cash flows and changes in financial position of the
Company, the Consolidated Subsidiaries and Mystic Partners, LLC and
its subsidiaries, as the case may be, on the basis stated in the
Registration Statement at the respective dates or for the
respective periods to which they apply; such statements and related
schedules and notes have been prepared in accordance with generally
accepted accounting principles consistently applied throughout the
periods involved, except as disclosed therein; and the other
financial and statistical information and data set forth in the
Registration Statement and Prospectus is accurately presented and
prepared on a basis consistent with such financial statements and
the books and records of the Company, the Consolidated Subsidiaries
and Mystic Partners, LLC and its subsidiaries, as the case may
be. No other financial statements or schedules are
required by Form S-3 or otherwise to be included in the
Registration Statement or the Prospectus.
(u) Except
as disclosed in the Registration Statement and the Prospectus,
subsequent to the respective dates as of which such information is
given in the Registration Statement and the Prospectus, (i) neither
the Company nor any Consolidated Subsidiary has incurred any
material liabilities or obligations, indirect, direct or
contingent, or entered into any transaction that is not in the
ordinary course of business, (ii) neither the Company nor any
Consolidated Subsidiary has sustained any material loss or
interference with its business or properties from fire, flood,
windstorm, accident or other calamity, whether or not covered by
insurance, (iii) except for regular quarterly dividends, neither
the Company nor any Consolidated Subsidiary has paid or declared
any dividends or other distributions with respect to its capital
shares and the Company is not in default under the terms of any
class of capital shares of the Company or any outstanding debt
obligations, (iv) there has not been any change in the authorized
or outstanding capital stock of the Company (other than the
issuance of Common Shares to the trustees, employees and officers
of the Company and its affiliates pursuant to the Company’s
equity incentive plan and upon exchange or conversion of other
outstanding securities) or any material change in the indebtedness
of the Company, (other than in the ordinary course of business and
borrowings under existing or future bank lines of credit) and (v)
there has not been any material adverse change, or any development
involving or that may reasonably be expected to result in a
Material Adverse Effect.
(v) The
Placement Shares to be sold under this Agreement have been or will
be approved for listing on the Exchange, subject to official notice
of issuance. The Shares are registered pursuant to
Section 12(b) of the Exchange Act, and the Company has taken no
action designed to, or likely to have the effect of, terminating
the registration of the Shares under the Exchange Act or delisting
any such securities from the Exchange, nor has the Company received
any notification that the Commission or the Exchange is
contemplating terminating such registration or listing.
(w) The
Company has not distributed and will not distribute any offering
material in connection with the offering and sale of the Shares to
be sold hereunder by CF&Co as principal or agent for the
Company, other than the Prospectus and the Registration
Statement.
(x) Other
than excepted activity pursuant to Regulation M under the Exchange
Act, the Company has not taken and will not take, directly or
indirectly, any action that constituted, or any action designed to,
or that might reasonably be expected to cause or result in or
constitute stabilization or manipulation of the price of any
security of the Company to facilitate the sale or resale of the
Shares or for any other purpose.
(y) The
Company and each Subsidiary has timely filed (or valid extensions
to such filings have been obtained) all tax returns required to be
filed (other than certain state or local tax returns, as to which
the failure to file, individually or in the aggregate, would not
have a Material Adverse Effect), which returns are complete and
correct in all material respects, and neither the Company nor any
Subsidiary is in default in the payment of any taxes that were
payable pursuant to said returns or any assessments with respect
thereto (whether imposed directly or through witholding). Except as
disclosed in the Prospectus (as amended or supplemented), all
deficiencies asserted as a result of any federal, state, local or
foreign tax audits have been paid or finally settled and no issue
has been raised in any such audit that, by application of the same
or similar principles, reasonably could be expected to result in a
proposed deficiency for any other period not so audited. There are
no outstanding agreements or waivers extending the statutory period
of limitation applicable to any federal, state, local or foreign
tax return for any period. On each Settlement Date, all stock
transfer and other taxes that are required to be paid in connection
with the sale of the Placement Shares will have been fully paid by
the Company and all laws imposing such taxes will have been
complied with.
(z) Except
as set forth in the Prospectus (as amended or supplemented), there
are no transactions with “affiliates” (as defined in
Rule 405 promulgated under the Securities Act) or any officer,
director or security holder of the Company (whether or not an
affiliate) that are required by the Securities Act to be disclosed
in the Prospectus that have not been disclosed as
required. Additionally, no relationship, direct or
indirect, exists between the Company or any Consolidated Subsidiary
on the one hand, and the directors, officers, stockholders,
customers or suppliers of the Company or any such Subsidiary on the
other hand that is required by the Securities Act to be disclosed
in the Prospectus that is not so disclosed.
(aa) Neither
the Company nor any Consolidated Subsidiary is an “investment
company”, a company “controlled” by an
“investment company” or an “affiliated
person” of, or “promoter” or “principal
underwriter” for, an investment company within the meaning of
the Investment Company Act of 1940, as amended.
(bb) Each of
the Company and the Consolidated Subsidiaries has good and valid
title to all property (real and personal), free and clear of all
liens, claims, security interests or other encumbrances except (i)
such as are described in the Prospectus or (ii) such as do not or
will not materially adversely affect the Company or such
Consolidated Subsidiary’s use of the property or the conduct
of the business of the Company or its Consolidated Subsidiaries,
either individually or taken as a whole. All property (real and
personal) leased by the Company and the Consolidated Subsidiaries
is held under valid and enforceable leases with only such
exceptions as in the aggregate do not or will not materially
adversely affect the use of the property or the conduct of the
business of the Company or its Consolidated Subsidiaries, either
individually or taken as a whole.
(cc) The
Company and the Consolidated Subsidiaries have all permits,
licenses, franchises, approvals, consents and authorizations of
governmental or regulatory authorities (hereinafter
“permit” or “permits”) as are necessary to
own their properties and to conduct their business in the manner
described in the Prospectus, subject to such qualifications as may
be set forth in the Prospectus, except where the failure to have
obtained any such permit has not had and will not have a Material
Adverse Effect; each of the Company and the Consolidated
Subsidiaries has operated and is operating its business in material
compliance with all of its obligations with respect to each such
permit and no event has occurred that allows, or after notice or
lapse of time would allow, revocation or termination of any such
permit and except where such revocation or termination would not
have a Material Adverse Effect or result in any other material
impairment of the rights of any such permit, subject in each case
to such qualification as may be set forth in the Prospectus; and,
except as described in the Prospectus, such permits contain no
restrictions that are material to the Company and its Consolidated
Subsidiaries, taken as a whole.
(dd) The
Company has established, maintains and evaluates disclosure
controls and procedures (as such term is defined in Rule 13a-15 and
15d-15 under the Exchange Act) and “internal control over
financial reporting” (as such term is defined in Rule 13a-15
and 15d-15 under the Exchange Act) in accordance with such rules
and any related rules of the Commission or the Exchange; such
disclosure controls and procedures are designed to ensure that
material information relating to the Company, including its
Consolidated Subsidiaries, is made known to the Company’s
Chief Executive Officer and its Chief Financial Officer by others
within those entities, and except as disclosed in the
Company’s Annual Report on Form 10-K for the year ended
December 31, 2008, as amended, such disclosure controls and
procedures are effective to perform the functions for which they
were established.
(ee) Except
as disclosed in the Prospectus or any Issuer Free Writing
Prospectus, the Company and the Consolidated Subsidiaries maintain
a system of internal accounting controls sufficient to provide
reasonable assurance that: (i) transactions are executed in
accordance with management’s general or specific
authorization; (ii) transactions are recorded as necessary to
permit preparation of financial statements in conformity with
generally accepted accounting principles and to maintain
accountability for assets; (iii) access to assets is permitted only
in accordance with management’s general or specific
authorization; and (iv) the recorded accountability for assets is
compared with existing assets at reasonable intervals and
appropriate action is taken with respect to any differences; and,
to the Company’s and the Operating Partnership’s
knowledge, neither the Company, the Operating Partnership nor any
Consolidated Subsidiary, employee or agent thereof, has made any
payment of funds of the Company, the Operating Partnership or any
Consolidated Subsidiary, as the case may be, or received or
retained any funds, and no funds of the Company, the Operating
Partnership or any Consolidated Subsidiary, as the case may be,
have been set aside to be used for any payment, in each case in
violation of any law, rule or regulation.
(ff) Based
on evaluations of its internal controls over financial reporting,
the Company is not aware of (i) any material weakness in the design
or operation of internal control over financial reporting which are
reasonably likely to adversely affect the Company's ability to
record, process, summarize and report financial information; or
(ii) any fraud, whether or not material, that involves management
or other employees who have a significant role in the Company's
internal control over financial reporting.
(gg) None of
the Company, any Consolidated Subsidiary or, to the Company's
knowledge, any employee or agent of the Company or of any
Consolidated Subsidiary, has, directly or indirectly, (i) made any
unlawful contribution to any candidate for political office, or
failed to disclose fully any contribution in violation of law or
(ii) made any payment to any federal, state, local or foreign
governmental official, or other person charged with similar public
or quasi-public duties, other than payments required or permitted
by the laws of the United States or any jurisdiction thereof or
applicable foreign jurisdictions.
(hh) The
Company and the Consolidated Subsidiaries are (i) in compliance
with any and all applicable federal, state, local and foreign laws
and regulations relating to the protection of human health and
safety, the environment or hazardous or toxic substances or wastes,
pollutants or contaminants (“ Environmental Laws
”), (ii) have received all permits, licenses or other
approvals required of them under applicable Environmental Laws to
conduct their respective businesses and (iii) are in compliance
with all terms and conditions of any such permit, license or
approval, except in each case as would not, individually or in the
aggregate, have a Material Adverse Effect. Neither the Company nor
any Consolidated Subsidiary has been named as a “potentially
responsible party” under the Com
|